nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—SLC10A1—Progesterone—uterine cancer	0.129	0.154	CbGbCtD
Probenecid—ABCC6—Dactinomycin—uterine cancer	0.118	0.142	CbGbCtD
Probenecid—ABCC6—Etoposide—uterine cancer	0.0667	0.0799	CbGbCtD
Probenecid—ABCC6—Doxorubicin—uterine cancer	0.0455	0.0545	CbGbCtD
Probenecid—ABCC1—Progesterone—uterine cancer	0.044	0.0527	CbGbCtD
Probenecid—SLC22A2—Progesterone—uterine cancer	0.0398	0.0478	CbGbCtD
Probenecid—ABCC1—Dactinomycin—uterine cancer	0.0349	0.0418	CbGbCtD
Probenecid—SLC22A1—Progesterone—uterine cancer	0.0346	0.0415	CbGbCtD
Probenecid—SLC22A5—Dactinomycin—uterine cancer	0.0331	0.0397	CbGbCtD
Probenecid—ABCC3—Etoposide—uterine cancer	0.032	0.0384	CbGbCtD
Probenecid—ABCC1—Epirubicin—uterine cancer	0.0252	0.0303	CbGbCtD
Probenecid—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0237	0.0284	CbGbCtD
Probenecid—ABCC3—Doxorubicin—uterine cancer	0.0219	0.0262	CbGbCtD
Probenecid—ABCC1—Etoposide—uterine cancer	0.0197	0.0236	CbGbCtD
Probenecid—ABCC2—Carboplatin—uterine cancer	0.0173	0.0208	CbGbCtD
Probenecid—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0165	0.0198	CbGbCtD
Probenecid—CYP2C8—Progesterone—uterine cancer	0.0157	0.0188	CbGbCtD
Probenecid—ABCC2—Etoposide—uterine cancer	0.0146	0.0175	CbGbCtD
Probenecid—ABCC1—Doxorubicin—uterine cancer	0.0134	0.0161	CbGbCtD
Probenecid—CYP2C19—Progesterone—uterine cancer	0.0131	0.0158	CbGbCtD
Probenecid—CYP2C9—Progesterone—uterine cancer	0.0109	0.0131	CbGbCtD
Probenecid—ABCB1—Progesterone—uterine cancer	0.0106	0.0127	CbGbCtD
Probenecid—ABCC2—Doxorubicin—uterine cancer	0.00993	0.0119	CbGbCtD
Probenecid—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00959	0.0115	CbGbCtD
Probenecid—ABCB1—Dactinomycin—uterine cancer	0.00841	0.0101	CbGbCtD
Probenecid—CYP2C8—Etoposide—uterine cancer	0.00701	0.00841	CbGbCtD
Probenecid—CYP3A4—Progesterone—uterine cancer	0.00635	0.00762	CbGbCtD
Probenecid—ABCB1—Etoposide—uterine cancer	0.00475	0.00569	CbGbCtD
Probenecid—ABCB1—Doxorubicin—uterine cancer	0.00324	0.00388	CbGbCtD
Probenecid—PANX1—myometrium—uterine cancer	0.00317	0.041	CbGeAlD
Probenecid—Nephrotic syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00313	0.066	CcSEcCtD
Probenecid—SLC22A12—renal system—uterine cancer	0.00304	0.0394	CbGeAlD
Probenecid—ABCC6—Podofilox—Etoposide—uterine cancer	0.00293	1	CbGdCrCtD
Probenecid—Hepatic necrosis—Progesterone—uterine cancer	0.00287	0.0606	CcSEcCtD
Probenecid—CYP3A4—Etoposide—uterine cancer	0.00284	0.00341	CbGbCtD
Probenecid—PANX1—decidua—uterine cancer	0.00235	0.0304	CbGeAlD
Probenecid—PANX1—endometrium—uterine cancer	0.00223	0.0288	CbGeAlD
Probenecid—PANX1—mammalian vulva—uterine cancer	0.00216	0.0279	CbGeAlD
Probenecid—SLC2A9—renal system—uterine cancer	0.00209	0.027	CbGeAlD
Probenecid—PANX1—uterus—uterine cancer	0.00205	0.0266	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—uterine cancer	0.00194	0.00232	CbGbCtD
Probenecid—ABCC11—female reproductive system—uterine cancer	0.00177	0.0229	CbGeAlD
Probenecid—SLC16A7—myometrium—uterine cancer	0.00169	0.0219	CbGeAlD
Probenecid—PANX1—female gonad—uterine cancer	0.00168	0.0217	CbGeAlD
Probenecid—SLC2A9—female reproductive system—uterine cancer	0.00167	0.0217	CbGeAlD
Probenecid—PANX1—vagina—uterine cancer	0.00167	0.0216	CbGeAlD
Probenecid—ABCC11—female gonad—uterine cancer	0.00161	0.0208	CbGeAlD
Probenecid—SLC2A9—female gonad—uterine cancer	0.00152	0.0197	CbGeAlD
Probenecid—SLC16A7—uterine cervix—uterine cancer	0.00132	0.0171	CbGeAlD
Probenecid—ABCC6—renal system—uterine cancer	0.00127	0.0164	CbGeAlD
Probenecid—SLC16A7—decidua—uterine cancer	0.00126	0.0162	CbGeAlD
Probenecid—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.0257	CcSEcCtD
Probenecid—SLC16A7—mammalian vulva—uterine cancer	0.00115	0.0149	CbGeAlD
Probenecid—SLC10A1—renal system—uterine cancer	0.00115	0.0149	CbGeAlD
Probenecid—Aplastic anaemia—Dactinomycin—uterine cancer	0.00111	0.0234	CcSEcCtD
Probenecid—SLC16A7—uterus—uterine cancer	0.0011	0.0142	CbGeAlD
Probenecid—SLCO1C1—renal system—uterine cancer	0.00108	0.014	CbGeAlD
Probenecid—PANX1—lymph node—uterine cancer	0.00108	0.014	CbGeAlD
Probenecid—SLC22A11—renal system—uterine cancer	0.00105	0.0136	CbGeAlD
Probenecid—SLC22A7—renal system—uterine cancer	0.00103	0.0133	CbGeAlD
Probenecid—SLC16A7—female reproductive system—uterine cancer	0.000988	0.0128	CbGeAlD
Probenecid—SLC2A9—lymph node—uterine cancer	0.00098	0.0127	CbGeAlD
Probenecid—Pain—Carboplatin—uterine cancer	0.00097	0.0205	CcSEcCtD
Probenecid—Pollakiuria—Progesterone—uterine cancer	0.000968	0.0204	CcSEcCtD
Probenecid—SLC10A1—female reproductive system—uterine cancer	0.000923	0.0119	CbGeAlD
Probenecid—ABCC5—uterine cervix—uterine cancer	0.000923	0.0119	CbGeAlD
Probenecid—SLC22A2—renal system—uterine cancer	0.000914	0.0118	CbGeAlD
Probenecid—Body temperature increased—Carboplatin—uterine cancer	0.000897	0.0189	CcSEcCtD
Probenecid—SLC16A7—vagina—uterine cancer	0.000894	0.0116	CbGeAlD
Probenecid—ABCC5—decidua—uterine cancer	0.000879	0.0114	CbGeAlD
Probenecid—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.000877	0.0185	CcSEcCtD
Probenecid—SLC16A1—epithelium—uterine cancer	0.000847	0.0109	CbGeAlD
Probenecid—SLC22A11—female reproductive system—uterine cancer	0.000843	0.0109	CbGeAlD
Probenecid—SLC16A1—decidua—uterine cancer	0.0008	0.0103	CbGeAlD
Probenecid—Erythema multiforme—Progesterone—uterine cancer	0.000793	0.0167	CcSEcCtD
Probenecid—SLC16A1—renal system—uterine cancer	0.000785	0.0102	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.000772	0.0163	CcSEcCtD
Probenecid—SLC16A1—endometrium—uterine cancer	0.000759	0.00982	CbGeAlD
Probenecid—Alopecia—Progesterone—uterine cancer	0.000741	0.0156	CcSEcCtD
Probenecid—ABCC3—decidua—uterine cancer	0.000738	0.00955	CbGeAlD
Probenecid—ABCC3—renal system—uterine cancer	0.000725	0.00937	CbGeAlD
Probenecid—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000719	0.0152	CcSEcCtD
Probenecid—ABCC1—myometrium—uterine cancer	0.000701	0.00906	CbGeAlD
Probenecid—SLC16A1—uterus—uterine cancer	0.0007	0.00905	CbGeAlD
Probenecid—Anaemia—Progesterone—uterine cancer	0.000675	0.0142	CcSEcCtD
Probenecid—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000672	0.0142	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.000655	0.0138	CcSEcCtD
Probenecid—SLC22A1—renal system—uterine cancer	0.000646	0.00835	CbGeAlD
Probenecid—ABCC5—female gonad—uterine cancer	0.000629	0.00814	CbGeAlD
Probenecid—SLC16A1—female reproductive system—uterine cancer	0.000629	0.00813	CbGeAlD
Probenecid—ABCC5—vagina—uterine cancer	0.000625	0.00809	CbGeAlD
Probenecid—SLCO1A2—renal system—uterine cancer	0.000622	0.00804	CbGeAlD
Probenecid—SLC22A5—myometrium—uterine cancer	0.000616	0.00797	CbGeAlD
Probenecid—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.0129	CcSEcCtD
Probenecid—ABCC4—renal system—uterine cancer	0.000598	0.00774	CbGeAlD
Probenecid—Anaphylactic shock—Progesterone—uterine cancer	0.000596	0.0126	CcSEcCtD
Probenecid—SLC22A8—renal system—uterine cancer	0.000594	0.00768	CbGeAlD
Probenecid—ABCC3—female reproductive system—uterine cancer	0.000581	0.00751	CbGeAlD
Probenecid—ABCC2—renal system—uterine cancer	0.000579	0.00749	CbGeAlD
Probenecid—SLC16A7—lymph node—uterine cancer	0.000578	0.00748	CbGeAlD
Probenecid—SLC16A1—female gonad—uterine cancer	0.000572	0.0074	CbGeAlD
Probenecid—Anorexia—Progesterone—uterine cancer	0.000568	0.012	CcSEcCtD
Probenecid—Erythema multiforme—Dactinomycin—uterine cancer	0.000561	0.0118	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000559	0.0118	CcSEcCtD
Probenecid—Flushing—Dactinomycin—uterine cancer	0.00055	0.0116	CcSEcCtD
Probenecid—ABCC1—uterine cervix—uterine cancer	0.000545	0.00705	CbGeAlD
Probenecid—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00054	0.0114	CcSEcCtD
Probenecid—ABCC4—uterus—uterine cancer	0.000533	0.00689	CbGeAlD
Probenecid—ABCC3—female gonad—uterine cancer	0.000528	0.00683	CbGeAlD
Probenecid—Alopecia—Dactinomycin—uterine cancer	0.000524	0.011	CcSEcCtD
Probenecid—ABCC1—decidua—uterine cancer	0.00052	0.00672	CbGeAlD
Probenecid—Decreased appetite—Progesterone—uterine cancer	0.000518	0.0109	CcSEcCtD
Probenecid—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000515	0.0109	CcSEcCtD
Probenecid—Pain—Progesterone—uterine cancer	0.00051	0.0107	CcSEcCtD
Probenecid—SLCO1C1—lymph node—uterine cancer	0.000508	0.00656	CbGeAlD
Probenecid—ABCC1—endometrium—uterine cancer	0.000493	0.00638	CbGeAlD
Probenecid—SLC22A5—uterine cervix—uterine cancer	0.00048	0.0062	CbGeAlD
Probenecid—ABCC4—female reproductive system—uterine cancer	0.000479	0.0062	CbGeAlD
Probenecid—ABCC1—mammalian vulva—uterine cancer	0.000477	0.00617	CbGeAlD
Probenecid—Anaemia—Dactinomycin—uterine cancer	0.000477	0.0101	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000474	0.00999	CcSEcCtD
Probenecid—Urticaria—Progesterone—uterine cancer	0.000473	0.00998	CcSEcCtD
Probenecid—Body temperature increased—Progesterone—uterine cancer	0.000471	0.00993	CcSEcCtD
Probenecid—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000469	0.0099	CcSEcCtD
Probenecid—SLC22A1—vagina—uterine cancer	0.000468	0.00605	CbGeAlD
Probenecid—ABCC2—female reproductive system—uterine cancer	0.000464	0.006	CbGeAlD
Probenecid—Leukopenia—Dactinomycin—uterine cancer	0.000462	0.00974	CcSEcCtD
Probenecid—ABCC1—uterus—uterine cancer	0.000455	0.00588	CbGeAlD
Probenecid—Aplastic anaemia—Epirubicin—uterine cancer	0.00045	0.00948	CcSEcCtD
Probenecid—SLC22A5—renal system—uterine cancer	0.000449	0.0058	CbGeAlD
Probenecid—Hypersensitivity—Progesterone—uterine cancer	0.000439	0.00926	CcSEcCtD
Probenecid—ABCC4—female gonad—uterine cancer	0.000436	0.00564	CbGeAlD
Probenecid—CYP2C8—renal system—uterine cancer	0.000434	0.00562	CbGeAlD
Probenecid—SLC22A5—endometrium—uterine cancer	0.000434	0.00561	CbGeAlD
Probenecid—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000429	0.00904	CcSEcCtD
Probenecid—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000427	0.009	CcSEcCtD
Probenecid—Pruritus—Progesterone—uterine cancer	0.000422	0.00889	CcSEcCtD
Probenecid—CYP2C8—endometrium—uterine cancer	0.00042	0.00543	CbGeAlD
Probenecid—Aplastic anaemia—Doxorubicin—uterine cancer	0.000416	0.00877	CcSEcCtD
Probenecid—Erythema multiforme—Etoposide—uterine cancer	0.000406	0.00855	CcSEcCtD
Probenecid—ABCC5—lymph node—uterine cancer	0.000404	0.00523	CbGeAlD
Probenecid—Anorexia—Dactinomycin—uterine cancer	0.000402	0.00846	CcSEcCtD
Probenecid—Flushing—Etoposide—uterine cancer	0.000398	0.0084	CcSEcCtD
Probenecid—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000398	0.00839	CcSEcCtD
Probenecid—Dizziness—Progesterone—uterine cancer	0.000394	0.00831	CcSEcCtD
Probenecid—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000382	0.00805	CcSEcCtD
Probenecid—Alopecia—Etoposide—uterine cancer	0.000379	0.00799	CcSEcCtD
Probenecid—Vomiting—Progesterone—uterine cancer	0.000379	0.00799	CcSEcCtD
Probenecid—Dermatitis—Progesterone—uterine cancer	0.000375	0.00791	CcSEcCtD
Probenecid—Headache—Progesterone—uterine cancer	0.000373	0.00787	CcSEcCtD
Probenecid—ABCC1—female gonad—uterine cancer	0.000372	0.00481	CbGeAlD
Probenecid—ABCC1—vagina—uterine cancer	0.00037	0.00478	CbGeAlD
Probenecid—SLC16A1—lymph node—uterine cancer	0.000368	0.00476	CbGeAlD
Probenecid—Decreased appetite—Dactinomycin—uterine cancer	0.000366	0.00772	CcSEcCtD
Probenecid—CYP2C19—vagina—uterine cancer	0.00036	0.00466	CbGeAlD
Probenecid—Pain—Dactinomycin—uterine cancer	0.00036	0.00759	CcSEcCtD
Probenecid—SLC22A5—female reproductive system—uterine cancer	0.000359	0.00465	CbGeAlD
Probenecid—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.00753	CcSEcCtD
Probenecid—Nausea—Progesterone—uterine cancer	0.000354	0.00746	CcSEcCtD
Probenecid—CYP2C8—female reproductive system—uterine cancer	0.000348	0.0045	CbGeAlD
Probenecid—Anaemia—Etoposide—uterine cancer	0.000345	0.00728	CcSEcCtD
Probenecid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000343	0.00724	CcSEcCtD
Probenecid—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00034	0.00717	CcSEcCtD
Probenecid—ABCC3—lymph node—uterine cancer	0.00034	0.00439	CbGeAlD
Probenecid—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000338	0.00713	CcSEcCtD
Probenecid—Leukopenia—Etoposide—uterine cancer	0.000334	0.00705	CcSEcCtD
Probenecid—Body temperature increased—Dactinomycin—uterine cancer	0.000333	0.00702	CcSEcCtD
Probenecid—SLC22A5—female gonad—uterine cancer	0.000327	0.00423	CbGeAlD
Probenecid—SLC22A5—vagina—uterine cancer	0.000325	0.0042	CbGeAlD
Probenecid—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000321	0.00676	CcSEcCtD
Probenecid—CYP2C8—vagina—uterine cancer	0.000315	0.00407	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000313	0.0066	CcSEcCtD
Probenecid—Hypersensitivity—Dactinomycin—uterine cancer	0.00031	0.00654	CcSEcCtD
Probenecid—CYP2C9—female reproductive system—uterine cancer	0.000309	0.004	CbGeAlD
Probenecid—Anaphylactic shock—Etoposide—uterine cancer	0.000305	0.00643	CcSEcCtD
Probenecid—CYP3A4—renal system—uterine cancer	0.000294	0.00381	CbGeAlD
Probenecid—Anorexia—Etoposide—uterine cancer	0.000291	0.00613	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00029	0.00611	CcSEcCtD
Probenecid—ALB—lymph node—uterine cancer	0.00029	0.00375	CbGeAlD
Probenecid—ABCB1—myometrium—uterine cancer	0.000286	0.0037	CbGeAlD
Probenecid—ABCC4—lymph node—uterine cancer	0.00028	0.00363	CbGeAlD
Probenecid—Pollakiuria—Epirubicin—uterine cancer	0.000278	0.00585	CcSEcCtD
Probenecid—ABCC2—lymph node—uterine cancer	0.000271	0.00351	CbGeAlD
Probenecid—Vomiting—Dactinomycin—uterine cancer	0.000268	0.00565	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000266	0.0056	CcSEcCtD
Probenecid—Decreased appetite—Etoposide—uterine cancer	0.000265	0.00559	CcSEcCtD
Probenecid—Pain—Etoposide—uterine cancer	0.000261	0.0055	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—uterine cancer	0.000257	0.00541	CcSEcCtD
Probenecid—Haematuria—Epirubicin—uterine cancer	0.000255	0.00539	CcSEcCtD
Probenecid—Nausea—Dactinomycin—uterine cancer	0.00025	0.00527	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000246	0.00518	CcSEcCtD
Probenecid—Urticaria—Etoposide—uterine cancer	0.000242	0.00511	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—uterine cancer	0.000241	0.00508	CcSEcCtD
Probenecid—ABCC1—lymph node—uterine cancer	0.000239	0.00309	CbGeAlD
Probenecid—Haematuria—Doxorubicin—uterine cancer	0.000236	0.00498	CcSEcCtD
Probenecid—CYP3A4—female reproductive system—uterine cancer	0.000236	0.00305	CbGeAlD
Probenecid—Erythema multiforme—Epirubicin—uterine cancer	0.000227	0.00479	CcSEcCtD
Probenecid—Hypersensitivity—Etoposide—uterine cancer	0.000225	0.00473	CcSEcCtD
Probenecid—ABCB1—epithelium—uterine cancer	0.000225	0.0029	CbGeAlD
Probenecid—Flushing—Epirubicin—uterine cancer	0.000223	0.00471	CcSEcCtD
Probenecid—ABCB1—uterine cervix—uterine cancer	0.000223	0.00288	CbGeAlD
Probenecid—Pruritus—Etoposide—uterine cancer	0.000216	0.00455	CcSEcCtD
Probenecid—Alopecia—Epirubicin—uterine cancer	0.000213	0.00448	CcSEcCtD
Probenecid—ABCB1—decidua—uterine cancer	0.000212	0.00274	CbGeAlD
Probenecid—Erythema multiforme—Doxorubicin—uterine cancer	0.00021	0.00444	CcSEcCtD
Probenecid—SLC22A5—lymph node—uterine cancer	0.00021	0.00272	CbGeAlD
Probenecid—ABCB1—renal system—uterine cancer	0.000208	0.00269	CbGeAlD
Probenecid—Flushing—Doxorubicin—uterine cancer	0.000207	0.00435	CcSEcCtD
Probenecid—Dizziness—Etoposide—uterine cancer	0.000202	0.00425	CcSEcCtD
Probenecid—ABCB1—endometrium—uterine cancer	0.000201	0.0026	CbGeAlD
Probenecid—Alopecia—Doxorubicin—uterine cancer	0.000197	0.00415	CcSEcCtD
Probenecid—ABCB1—mammalian vulva—uterine cancer	0.000195	0.00252	CbGeAlD
Probenecid—Vomiting—Etoposide—uterine cancer	0.000194	0.00409	CcSEcCtD
Probenecid—Anaemia—Epirubicin—uterine cancer	0.000194	0.00408	CcSEcCtD
Probenecid—Dermatitis—Etoposide—uterine cancer	0.000192	0.00405	CcSEcCtD
Probenecid—Headache—Etoposide—uterine cancer	0.000191	0.00403	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—uterine cancer	0.000187	0.00395	CcSEcCtD
Probenecid—ABCB1—uterus—uterine cancer	0.000186	0.0024	CbGeAlD
Probenecid—Nausea—Etoposide—uterine cancer	0.000181	0.00382	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—uterine cancer	0.000179	0.00377	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—uterine cancer	0.000173	0.00366	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—uterine cancer	0.000171	0.0036	CcSEcCtD
Probenecid—ABCB1—female reproductive system—uterine cancer	0.000167	0.00216	CbGeAlD
Probenecid—Anorexia—Epirubicin—uterine cancer	0.000163	0.00343	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—uterine cancer	0.000158	0.00333	CcSEcCtD
Probenecid—ABCB1—female gonad—uterine cancer	0.000152	0.00196	CbGeAlD
Probenecid—ABCB1—vagina—uterine cancer	0.000151	0.00195	CbGeAlD
Probenecid—Anorexia—Doxorubicin—uterine cancer	0.000151	0.00318	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—uterine cancer	0.000149	0.00313	CcSEcCtD
Probenecid—Pain—Epirubicin—uterine cancer	0.000146	0.00308	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—uterine cancer	0.000137	0.0029	CcSEcCtD
Probenecid—Urticaria—Epirubicin—uterine cancer	0.000136	0.00286	CcSEcCtD
Probenecid—Pain—Doxorubicin—uterine cancer	0.000135	0.00285	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—uterine cancer	0.000135	0.00285	CcSEcCtD
Probenecid—Hypersensitivity—Epirubicin—uterine cancer	0.000126	0.00265	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—uterine cancer	0.000126	0.00265	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—uterine cancer	0.000125	0.00263	CcSEcCtD
Probenecid—Pruritus—Epirubicin—uterine cancer	0.000121	0.00255	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—uterine cancer	0.000117	0.00246	CcSEcCtD
Probenecid—Dizziness—Epirubicin—uterine cancer	0.000113	0.00238	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—uterine cancer	0.000112	0.00236	CcSEcCtD
Probenecid—Vomiting—Epirubicin—uterine cancer	0.000109	0.00229	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—uterine cancer	0.000108	0.00227	CcSEcCtD
Probenecid—Headache—Epirubicin—uterine cancer	0.000107	0.00226	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—uterine cancer	0.000105	0.0022	CcSEcCtD
Probenecid—Nausea—Epirubicin—uterine cancer	0.000102	0.00214	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—uterine cancer	0.000101	0.00212	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—uterine cancer	9.96e-05	0.0021	CcSEcCtD
Probenecid—Headache—Doxorubicin—uterine cancer	9.91e-05	0.00209	CcSEcCtD
Probenecid—ABCB1—lymph node—uterine cancer	9.76e-05	0.00126	CbGeAlD
Probenecid—Nausea—Doxorubicin—uterine cancer	9.39e-05	0.00198	CcSEcCtD
Probenecid—SLC22A1—Metabolism—POLD1—uterine cancer	1.68e-05	0.000443	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—DCN—uterine cancer	1.68e-05	0.000442	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.68e-05	0.000441	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKR1C3—uterine cancer	1.66e-05	0.000437	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.63e-05	0.00043	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.62e-05	0.000427	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.62e-05	0.000427	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.61e-05	0.000423	CbGpPWpGaD
Probenecid—ABCC1—Disease—FBXW7—uterine cancer	1.59e-05	0.000418	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP11A1—uterine cancer	1.58e-05	0.000416	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.58e-05	0.000415	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKR1C1—uterine cancer	1.57e-05	0.000414	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—MTHFR—uterine cancer	1.51e-05	0.000398	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—RRM2—uterine cancer	1.51e-05	0.000396	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKR1C3—uterine cancer	1.49e-05	0.000393	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.49e-05	0.000392	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—STK11—uterine cancer	1.48e-05	0.000391	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CYP19A1—uterine cancer	1.48e-05	0.000391	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—KRAS—uterine cancer	1.48e-05	0.00039	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—DCN—uterine cancer	1.46e-05	0.000384	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.46e-05	0.000384	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.44e-05	0.00038	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—STAR—uterine cancer	1.44e-05	0.00038	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKR1B1—uterine cancer	1.44e-05	0.000377	CbGpPWpGaD
Probenecid—ALB—Metabolism—STAR—uterine cancer	1.44e-05	0.000377	CbGpPWpGaD
Probenecid—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.43e-05	0.000377	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.43e-05	0.000375	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.42e-05	0.000373	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—MTHFR—uterine cancer	1.41e-05	0.00037	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—RRM2—uterine cancer	1.4e-05	0.000369	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.39e-05	0.000367	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000362	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—EP300—uterine cancer	1.37e-05	0.000361	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—DCN—uterine cancer	1.36e-05	0.000358	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—PIK3CA—uterine cancer	1.36e-05	0.000358	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.35e-05	0.000355	CbGpPWpGaD
Probenecid—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	1.34e-05	0.000351	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.33e-05	0.00035	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TP53—uterine cancer	1.32e-05	0.000347	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000342	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—VEGFA—uterine cancer	1.3e-05	0.000342	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CYP19A1—uterine cancer	1.29e-05	0.00034	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—STK11—uterine cancer	1.29e-05	0.00034	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—STAR—uterine cancer	1.29e-05	0.000339	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.29e-05	0.000339	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—NRAS—uterine cancer	1.28e-05	0.000338	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP11A1—uterine cancer	1.28e-05	0.000338	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.28e-05	0.000336	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.27e-05	0.000335	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—HRAS—uterine cancer	1.26e-05	0.000331	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—STAR—uterine cancer	1.26e-05	0.000331	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKR1B1—uterine cancer	1.26e-05	0.000331	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN2B—uterine cancer	1.25e-05	0.000328	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.24e-05	0.000327	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.21e-05	0.000319	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKR1C3—uterine cancer	1.21e-05	0.000319	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.19e-05	0.000312	CbGpPWpGaD
Probenecid—ABCC5—Disease—ERBB2—uterine cancer	1.18e-05	0.00031	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—STAR—uterine cancer	1.17e-05	0.000309	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.17e-05	0.000309	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—STK11—uterine cancer	1.16e-05	0.000306	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.000306	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.16e-05	0.000305	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.16e-05	0.000304	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.14e-05	0.0003	CbGpPWpGaD
Probenecid—ABCC1—Disease—SMAD3—uterine cancer	1.14e-05	0.000299	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—POLD1—uterine cancer	1.13e-05	0.000298	CbGpPWpGaD
Probenecid—ALB—Metabolism—POLD1—uterine cancer	1.13e-05	0.000296	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.12e-05	0.000296	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—MTHFR—uterine cancer	1.12e-05	0.000294	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—AKT1—uterine cancer	1.11e-05	0.000293	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—KRAS—uterine cancer	1.11e-05	0.000291	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PTEN—uterine cancer	1.1e-05	0.000289	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—HRAS—uterine cancer	1.1e-05	0.000289	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.09e-05	0.000287	CbGpPWpGaD
Probenecid—ABCC5—Disease—CDKN1B—uterine cancer	1.09e-05	0.000287	CbGpPWpGaD
Probenecid—ABCC1—Disease—FGFR2—uterine cancer	1.08e-05	0.000285	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.07e-05	0.000282	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.07e-05	0.000282	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.06e-05	0.000279	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKR1C1—uterine cancer	1.05e-05	0.000277	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—EP300—uterine cancer	1.05e-05	0.000276	CbGpPWpGaD
Probenecid—ABCC1—Disease—MTHFR—uterine cancer	1.04e-05	0.000275	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.04e-05	0.000274	CbGpPWpGaD
Probenecid—ABCC5—Disease—CTNNB1—uterine cancer	1.03e-05	0.000271	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—HRAS—uterine cancer	1.02e-05	0.000269	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.02e-05	0.000267	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—STK11—uterine cancer	1.01e-05	0.000267	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.000267	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—POLD1—uterine cancer	1.01e-05	0.000266	CbGpPWpGaD
Probenecid—ABCC5—Disease—PTEN—uterine cancer	1.01e-05	0.000264	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—POLD1—uterine cancer	9.87e-06	0.00026	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.83e-06	0.000259	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—uterine cancer	9.82e-06	0.000258	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—MTHFR—uterine cancer	9.72e-06	0.000256	CbGpPWpGaD
Probenecid—ABCC5—Disease—EP300—uterine cancer	9.59e-06	0.000252	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.55e-06	0.000251	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKR1C1—uterine cancer	9.46e-06	0.000249	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—STK11—uterine cancer	9.44e-06	0.000248	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP19A1—uterine cancer	9.44e-06	0.000248	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—RRM2—uterine cancer	9.44e-06	0.000248	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—HRAS—uterine cancer	9.4e-06	0.000247	CbGpPWpGaD
Probenecid—ALB—Metabolism—RRM2—uterine cancer	9.39e-06	0.000247	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKR1C1—uterine cancer	9.23e-06	0.000243	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—POLD1—uterine cancer	9.22e-06	0.000242	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—DCN—uterine cancer	9.17e-06	0.000241	CbGpPWpGaD
Probenecid—ALB—Metabolism—DCN—uterine cancer	9.11e-06	0.00024	CbGpPWpGaD
Probenecid—ABCC5—Disease—NRAS—uterine cancer	8.97e-06	0.000236	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	8.91e-06	0.000234	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.78e-06	0.000231	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—MTHFR—uterine cancer	8.74e-06	0.00023	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP11A1—uterine cancer	8.64e-06	0.000227	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKR1C1—uterine cancer	8.62e-06	0.000227	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP11A1—uterine cancer	8.59e-06	0.000226	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.56e-06	0.000225	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.49e-06	0.000223	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—RRM2—uterine cancer	8.43e-06	0.000222	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTEN—uterine cancer	8.42e-06	0.000221	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—AKT1—uterine cancer	8.3e-06	0.000218	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—RRM2—uterine cancer	8.23e-06	0.000216	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—DCN—uterine cancer	8.18e-06	0.000215	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKR1C3—uterine cancer	8.16e-06	0.000215	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKR1C3—uterine cancer	8.11e-06	0.000213	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—EP300—uterine cancer	8.03e-06	0.000211	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—DCN—uterine cancer	7.99e-06	0.00021	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTEN—uterine cancer	7.83e-06	0.000206	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PIK3CA—uterine cancer	7.75e-06	0.000204	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—STAR—uterine cancer	7.75e-06	0.000204	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.75e-06	0.000204	CbGpPWpGaD
Probenecid—ABCC5—Disease—KRAS—uterine cancer	7.72e-06	0.000203	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.71e-06	0.000203	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.7e-06	0.000203	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—RRM2—uterine cancer	7.68e-06	0.000202	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—MTHFR—uterine cancer	7.61e-06	0.0002	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP11A1—uterine cancer	7.52e-06	0.000198	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—EP300—uterine cancer	7.47e-06	0.000196	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—DCN—uterine cancer	7.46e-06	0.000196	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	7.28e-06	0.000192	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.28e-06	0.000191	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.17e-06	0.000189	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKR1C3—uterine cancer	7.1e-06	0.000187	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—MTHFR—uterine cancer	7.1e-06	0.000187	CbGpPWpGaD
Probenecid—ABCC5—Disease—PIK3CA—uterine cancer	7.09e-06	0.000187	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.03e-06	0.000185	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB2—uterine cancer	6.81e-06	0.000179	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKR1C3—uterine cancer	6.64e-06	0.000175	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—uterine cancer	6.56e-06	0.000173	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—STK11—uterine cancer	6.35e-06	0.000167	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP19A1—uterine cancer	6.35e-06	0.000167	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—uterine cancer	6.33e-06	0.000167	CbGpPWpGaD
Probenecid—ALB—Metabolism—STK11—uterine cancer	6.32e-06	0.000166	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP19A1—uterine cancer	6.32e-06	0.000166	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1B—uterine cancer	6.31e-06	0.000166	CbGpPWpGaD
Probenecid—ALB—Hemostasis—EP300—uterine cancer	6.21e-06	0.000163	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—uterine cancer	6.21e-06	0.000163	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—POLD1—uterine cancer	6.08e-06	0.00016	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.96e-06	0.000157	CbGpPWpGaD
Probenecid—ABCC1—Disease—CTNNB1—uterine cancer	5.96e-06	0.000157	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—uterine cancer	5.94e-06	0.000156	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.93e-06	0.000156	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—EP300—uterine cancer	5.92e-06	0.000156	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—uterine cancer	5.88e-06	0.000155	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—uterine cancer	5.81e-06	0.000153	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—uterine cancer	5.81e-06	0.000153	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—uterine cancer	5.79e-06	0.000152	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.69e-06	0.00015	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.69e-06	0.00015	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—STK11—uterine cancer	5.67e-06	0.000149	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.67e-06	0.000149	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.66e-06	0.000149	CbGpPWpGaD
Probenecid—ABCC1—Disease—EP300—uterine cancer	5.54e-06	0.000146	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—STK11—uterine cancer	5.54e-06	0.000146	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP19A1—uterine cancer	5.54e-06	0.000146	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—uterine cancer	5.52e-06	0.000145	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—uterine cancer	5.41e-06	0.000142	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.32e-06	0.00014	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—uterine cancer	5.18e-06	0.000136	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.17e-06	0.000136	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—STK11—uterine cancer	5.17e-06	0.000136	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—EP300—uterine cancer	5.15e-06	0.000136	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.08e-06	0.000134	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—RRM2—uterine cancer	5.07e-06	0.000133	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—uterine cancer	5e-06	0.000132	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—DCN—uterine cancer	4.92e-06	0.000129	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—uterine cancer	4.86e-06	0.000128	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.85e-06	0.000128	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—uterine cancer	4.85e-06	0.000128	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—MTHFR—uterine cancer	4.77e-06	0.000126	CbGpPWpGaD
Probenecid—ALB—Metabolism—MTHFR—uterine cancer	4.75e-06	0.000125	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—EP300—uterine cancer	4.64e-06	0.000122	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.64e-06	0.000122	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.63e-06	0.000122	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—uterine cancer	4.6e-06	0.000121	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—uterine cancer	4.51e-06	0.000119	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—uterine cancer	4.46e-06	0.000117	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—uterine cancer	4.45e-06	0.000117	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—uterine cancer	4.38e-06	0.000115	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.38e-06	0.000115	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—MTHFR—uterine cancer	4.26e-06	0.000112	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—uterine cancer	4.25e-06	0.000112	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—uterine cancer	4.24e-06	0.000111	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.21e-06	0.000111	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.18e-06	0.00011	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—MTHFR—uterine cancer	4.16e-06	0.000109	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—uterine cancer	4.1e-06	0.000108	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—EP300—uterine cancer	4.04e-06	0.000106	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—uterine cancer	3.95e-06	0.000104	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—MTHFR—uterine cancer	3.89e-06	0.000102	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—uterine cancer	3.81e-06	0.0001	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—uterine cancer	3.79e-06	9.97e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—EP300—uterine cancer	3.76e-06	9.9e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.76e-06	9.88e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—uterine cancer	3.75e-06	9.87e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—uterine cancer	3.58e-06	9.41e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—uterine cancer	3.43e-06	9.03e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.42e-06	9.01e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—STK11—uterine cancer	3.41e-06	8.97e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.41e-06	8.97e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—uterine cancer	3.35e-06	8.8e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—uterine cancer	3.12e-06	8.19e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—uterine cancer	2.99e-06	7.86e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—uterine cancer	2.8e-06	7.37e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—uterine cancer	2.79e-06	7.33e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—uterine cancer	2.66e-06	6.99e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—uterine cancer	2.64e-06	6.95e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTHFR—uterine cancer	2.56e-06	6.74e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—EP300—uterine cancer	2.53e-06	6.66e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—EP300—uterine cancer	2.52e-06	6.62e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—uterine cancer	2.44e-06	6.42e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—uterine cancer	2.37e-06	6.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—uterine cancer	2.31e-06	6.09e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—uterine cancer	2.28e-06	5.98e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—EP300—uterine cancer	2.26e-06	5.95e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—EP300—uterine cancer	2.21e-06	5.8e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—uterine cancer	2.16e-06	5.69e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—EP300—uterine cancer	2.06e-06	5.42e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.87e-06	4.93e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—uterine cancer	1.86e-06	4.9e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.67e-06	4.4e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—uterine cancer	1.63e-06	4.29e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—uterine cancer	1.53e-06	4.03e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.52e-06	4.01e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—uterine cancer	1.52e-06	4e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—uterine cancer	1.43e-06	3.75e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—uterine cancer	1.37e-06	3.59e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—EP300—uterine cancer	1.36e-06	3.58e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—uterine cancer	1.33e-06	3.51e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—uterine cancer	1.25e-06	3.28e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.01e-06	2.65e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—uterine cancer	8.22e-07	2.16e-05	CbGpPWpGaD
